Kyrgyzstan vs Uganda: Expected chances of death from non-communicable diseases, by gender
Kyrgyzstan
25.0%
in 2021
Uganda
25.0%
in 2021
Kyrgyzstan rank
59th
Uganda rank
59th
Expected chances of death from non-communicable diseases, by gender over time
- Kyrgyzstan
- Uganda
How they compare
Kyrgyzstan currently reports 25.0% against 25.0% in Uganda, a difference of 0.0%.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Kyrgyzstan ahead.
Kyrgyzstan ranks 59th and Uganda ranks 59th of 185 countries.
Kyrgyzstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40.4% | 32.0% | 8.4% | Kyrgyzstan |
| 2010s | 33.0% | 26.2% | 6.9% | Kyrgyzstan |
| 2020s | 26.8% | 25.4% | 1.4% | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher expected chances of death from non-communicable diseases, by gender, Kyrgyzstan or Uganda?
- Kyrgyzstan, at 25.0% against 25.0% in Uganda as of 2021.
- What is the difference in expected chances of death from non-communicable diseases, by gender between Kyrgyzstan and Uganda?
- 0.0%, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Uganda?
- 22 years are reported by both, from 2000 to 2021.
- How do Kyrgyzstan and Uganda rank globally for expected chances of death from non-communicable diseases, by gender?
- Kyrgyzstan ranks 59th and Uganda ranks 59th of 185 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Expected chances of death from non-communicable diseases, by gender. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated share of 30-year-olds who would die before their 70th birthday from common non-communicable diseases: any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease.